Li, Y. FDA Regulatory Milestones, Announcement Framing, and Biotechnology Stock Returns: Evidence on the Feasibility of an AI-Native Comparison, 2019-2026. HBEM 2026, 70, 94-102. https://doi.org/10.54097/n6naqe96.